Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Comprehensive Longitudinal Cohort Study in Type 2 Diabetes With High Risk of Cardiovascular Diseases in China (CCMR-3B Ext)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2011 by China Cardiometabolic Registries.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
VitalStrategic Research Institute
Gerontological Society of China
Chinese Medical Doctor Association
Information provided by (Responsible Party):
China Cardiometabolic Registries
ClinicalTrials.gov Identifier:
NCT01307410
First received: March 1, 2011
Last updated: February 13, 2013
Last verified: February 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)